Joohyuk Sohn Selected Research

Joohyuk Sohn Research Topics

Disease

85	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2010
29	Neoplasms (Cancer) 05/2024 - 01/2010
16	Disease Progression 03/2024 - 01/2019
14	Neutropenia 01/2024 - 12/2013
12	Neoplasm Metastasis (Metastasis) 06/2021 - 12/2013
5	Triple Negative Breast Neoplasms 01/2023 - 01/2014
5	Nausea 07/2020 - 09/2017
4	Diarrhea 06/2023 - 09/2017
3	Pathologic Complete Response 01/2023 - 01/2010
3	Febrile Neutropenia 08/2020 - 03/2016
2	Melanoma (Melanoma, Malignant) 04/2024 - 01/2020
2	Anemia 01/2024 - 11/2023
2	Exanthema (Rash) 06/2023 - 01/2021
2	Pneumonia (Pneumonitis) 01/2022 - 10/2020
2	Vomiting 07/2020 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2016
2	Fatigue 01/2020 - 09/2017
2	Alopecia (Baldness) 04/2019 - 06/2017
2	Circulating Neoplastic Cells 01/2017 - 04/2016
1	Thrombocytopenia (Thrombopenia) 01/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Hypokalemia 01/2021
1	Ovarian Epithelial Carcinoma 01/2021
1	Atrial Fibrillation 01/2021
1	Hyperglycemia 01/2021

Drug/Important Bio-Agent (IBA)

36	Hormones (Hormone)IBA 12/2023 - 12/2013
12	Fulvestrant (Faslodex)FDA Link 03/2024 - 09/2017
10	abemaciclibIBA 01/2023 - 09/2017
9	human ERBB2 proteinIBA 12/2023 - 11/2017
8	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2012
7	ErbB Receptors (EGF Receptor)IBA 10/2023 - 11/2018
7	Trastuzumab (Herceptin)FDA Link 10/2022 - 01/2012
6	Estrogen ReceptorsIBA 03/2024 - 01/2017
6	palbociclibIBA 01/2024 - 12/2019
6	Cyclin-Dependent Kinase 4IBA 12/2023 - 09/2017
6	AnthracyclinesIBA 11/2023 - 01/2010
6	taxaneIBA 04/2023 - 01/2010
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2012
6	Tamoxifen FDA LinkGeneric 04/2021 - 01/2018
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 12/2013
5	Aromatase InhibitorsIBA 03/2024 - 11/2017
5	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2024 - 10/2018
5	Messenger RNA (mRNA)IBA 11/2023 - 01/2017
5	Letrozole (Femara)FDA LinkGeneric 10/2023 - 01/2018
4	eribulin FDA Link 12/2023 - 04/2017
4	ribociclibIBA 03/2022 - 01/2018
4	Everolimus FDA Link 05/2021 - 11/2019
4	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2019 - 12/2013
3	ParaffinIBA 01/2018 - 01/2012
3	Epidermal Growth Factor (EGF)IBA 01/2016 - 01/2012
2	Phenobarbital (Luminal)FDA Link 04/2024 - 01/2023
2	giredestrantIBA 03/2024 - 11/2023
2	Vinorelbine (Navelbine)FDA LinkGeneric 11/2023 - 12/2019
2	Taxoids (Taxanes)IBA 11/2023 - 04/2023
2	Circulating Tumor DNAIBA 01/2023 - 01/2021
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2021
2	Biosimilar PharmaceuticalsIBA 10/2022 - 01/2021
2	trastuzumab deruxtecanIBA 01/2022 - 01/2020
2	Leuprolide (Lupron)FDA LinkGeneric 05/2021 - 01/2021
2	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2021
2	PlatinumIBA 01/2021 - 01/2020
2	Goserelin (Zoladex)FDA Link 01/2021 - 11/2018
2	HM781-36BIBA 12/2020 - 01/2019
2	Monoclonal AntibodiesIBA 01/2020 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2012
2	Lapatinib (GW572016)FDA Link 12/2019 - 10/2019
2	Gemcitabine FDA Link 11/2019 - 01/2019
2	Cyclin DIBA 01/2019 - 01/2019
2	Docetaxel (Taxotere)FDA Link 03/2016 - 12/2013
2	Formaldehyde (Formol)FDA Link 01/2015 - 01/2012
1	efineptakin alfaIBA 05/2024
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	EnzymesIBA 01/2024
1	NivolumabIBA 12/2023
1	Pemetrexed (MTA)FDA Link 11/2023
1	Estrogen Receptor AntagonistsIBA 11/2023
1	2- (N- phenethyl- N- propyl)amino- 5- hydroxytetralinIBA 10/2023
1	capivasertibIBA 06/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2023
1	pipoxolan (BR 18)IBA 10/2022
1	talazoparibIBA 10/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2021
1	AlpelisibIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	CT-P6IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	avelumabIBA 01/2021
1	NVP-BKM120IBA 01/2021
1	130-nm albumin-bound paclitaxelIBA 10/2020
1	LigandsIBA 10/2020

Therapy/Procedure

39	Therapeutics 03/2024 - 12/2013
27	Drug Therapy (Chemotherapy) 03/2024 - 12/2013
9	Neoadjuvant Therapy 01/2023 - 01/2010
5	Adjuvant Chemotherapy 01/2023 - 03/2016
2	Aftercare (After-Treatment) 06/2023 - 01/2018
2	Radiotherapy 01/2018 - 09/2017
1	Immunotherapy 05/2024
1	Drug Tapering 01/2021